-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P5CJz58EKyJPi4DxoZj9vMbaUZiimMCrElr3SUy4+gOJlGSEUGXYtvfaqgr24Q1c tQugqz70Lt8RMSsWtkmmWw== 0001209191-08-015470.txt : 20080304 0001209191-08-015470.hdr.sgml : 20080304 20080304154531 ACCESSION NUMBER: 0001209191-08-015470 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080229 FILED AS OF DATE: 20080304 DATE AS OF CHANGE: 20080304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLOGG PETER N CENTRAL INDEX KEY: 0001226287 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 08663590 BUSINESS ADDRESS: BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-29 0 0000064978 MERCK & CO INC (MRK) 0001226287 KELLOGG PETER N MERCK & CO., INC. ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 0 1 0 0 Exec. V.P. & C.F.O. Employee Stock Option 2008/02/29 (right to buy) 44.30 2008-02-29 4 A 0 62400 0.00 A 2009-02-28 2018-02-28 Common Stock 62400 62400 D Restricted Stock Units 2008/02/29 2008-02-29 4 A 0 11700 0.00 A 2011-02-28 2011-02-28 Common Stock 11700 11700 D The option vests in three equal annual installments beginning February 28, 2009. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Debra A. Bollwage as Attorney-in-Fact for Peter N. Kellogg 2008-03-04 -----END PRIVACY-ENHANCED MESSAGE-----